Clinical trajectories in the ultra-high risk for psychosis population

Schizophrenia Research

Volumn 197, Issue , 2018, Pages 550-556

  Polari, Andrea ^a,b   Lavoie, Suzie ^a,b   Yuen, Hok Pan ^a,b   Amminger, Paul ^a,b   Berger, Gregor ^c   Chen, Eric ^d   deHaan, Lieuwe ^e   Hartmann, Jessica ^a,b   Markulev, Connie ^a,b   Melville, Fritha ^a   Nieman, Dorien ^f   Nordentoft, Merete ^g   Riecher Rössler, Anita ^h   Smesny, Stefan ⁱ   Stratford, John ^a   Verma, Swapna ^j   Yung, Alison ^k   McGorry, Patrick ^a,b   Nelson, Barnaby ^a,b  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g Psykiatrisk Center københavn   (Denmark)

^h UNIVERSITY OF BASEL   (Switzerland)

ⁱ JENA UNIVERSITY HOSPITAL   (Germany)

^j INSTITUTE OF MENTAL HEALTH   (Singapore)

^k UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

Definitions; Recovery; Recurrence; Relapse; Remission; Transition to psychosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; RELAPSE; REMISSION; RISK ASSESSMENT; ULTRA HIGH RISK POPULATION; CLASSIFICATION; CLINICAL TRIAL; DISEASE EXACERBATION; LONGITUDINAL STUDY; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

ADOLESCENT; ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION; RISK; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

EID: 85042141929     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2018.01.022     Document Type: Article

References (67)

1. Addington, J., Cornblatt, B.A., Cadenhead, K.S., Cannon, T.D., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., Heinssen, R., At clinical high risk for psychosis: outcome for nonconverters. Am. J. Psychiatry 168:8 (2011), 800–805.
2. Andreasen, N.C., Scale For Assessing Negative Symptoms (SANS). 1984, University of Iowa, Iowa City.
3. Andreasen, N.C., Carpenter, W.T. Jr., Kane, J.M., Lasser, R.A., Marder, S.R., Weinberger, D.R., Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 162:3 (2005), 441–449.
4. APA, A.P.A., Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 2013 (Washington, D.C.).
5. Banati, R., Hickie, I.B., Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med. J. Aust. 190:4 Suppl (2009), S26–32.
6. Cannon, T.D., How schizophrenia develops: cognitive and brain mechanisms underlying onset of psychosis. Trends Cogn. Sci. 19:12 (2015), 744–756.
7. Carpenter, W.T., Attenuated psychosis syndrome: a new diagnostic class?. J. Nerv. Ment. Dis. 203:5 (2015), 325–327.
8. Carpenter, W.T., Schiffman, J., Diagnostic concepts in the context of clinical high risk/attenuated psychosis syndrome. Schizophr. Bull. 41:5 (2015), 1001–1002.
9. Carrion, R.E., Correll, C.U., Auther, A.M., Cornblatt, B.A., A severity-based clinical staging model for the psychosis prodrome: longitudinal findings from the New York recognition and prevention program. Schizophr. Bull. 43:1 (2017), 64–74.
10. Ciompi, L., Is there really a schizophrenia? The long-term course of psychotic phenomena. Br. J. Psychiatry 145:6 (1984), 636–640.
11. Clark, S.R., Schubert, K.O., Baune, B.T., Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome. J Neural Transm (Vienna) 122:1 (2015), 155–169.
12. Cornblatt, B.A., Lencz, T., Smith, C.W., Correll, C.U., Auther, A.M., Nakayama, E., The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 29:4 (2003), 633–651.
13. Emsley, R., Chiliza, B., Asmal, L., Lehloenya, K., The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry 24:2 (2011), 114–121.
14. Frank, E., Prien, R.F., Jarrett, R.B., Keller, M.B., Kupfer, D.J., Lavori, P.W., Rush, A.J., Weissman, M.M., Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch. Gen. Psychiatry 48:9 (1991), 851–855.
15. Fusar-Poli, P., The clinical high-risk state for psychosis (CHR-P), version II. Schizophr. Bull. 43:1 (2017), 44–47.
16. Fusar-Poli, P., Bonoldi, I., Yung, A.R., Borgwardt, S., Kempton, M.J., Valmaggia, L., Barale, F., Caverzasi, E., McGuire, P., Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 69:3 (2012), 220–229.
17. Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rossler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L.J., Valmaggia, L., Cannon, T., Velthorst, E., De Haan, L., Cornblatt, B., Bonoldi, I., Birchwood, M., McGlashan, T., Carpenter, W., McGorry, P., Klosterkotter, J., McGuire, P., Yung, A., The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70:1 (2013), 107–120.
18. Fusar-Poli, P., Rocchetti, M., Sardella, A., Avila, A., Brandizzi, M., Caverzasi, E., Politi, P., Ruhrmann, S., McGuire, P., Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. Br. J. Psychiatry 207:3 (2015), 198–206.
19. Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Woods, S.W., Addington, J., Nelson, B., Nieman, D.H., Stahl, D.R., Rutigliano, G., Riecher-Rossler, A., Simon, A.E., Mizuno, M., Lee, T.Y., Kwon, J.S., Lam, M.M., Perez, J., Keri, S., Amminger, P., Metzler, S., Kawohl, W., Rossler, W., Lee, J., Labad, J., Ziermans, T., An, S.K., Liu, C.C., Woodberry, K.A., Braham, A., Corcoran, C., McGorry, P., Yung, A.R., McGuire, P.K., Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry 73:2 (2016), 113–120.
20. Georgopoulos, G., Stowkowy, J., Liu, L., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., Bearden, C.E., Mathalon, D.H., Addington, J., The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry, 2017, 1–6.
21. Goldman, H.H., Skodol, A.E., Lave, T.R., Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry 149:9 (1992), 1148–1156.
22. Hartmann, J.A., Yuen, H.P., McGorry, P.D., Yung, A.R., Lin, A., Wood, S.J., Lavoie, S., Nelson, B., Declining transition rates to psychotic disorder in “ultra-high risk” clients: investigation of a dilution effect. Schizophr. Res. 170:1 (2016), 130–136.
23. Hartmann, J.A., McGorry, P., Schmidt, S.J., Amminger, G.P., Yuen, H.P., Markulev, C., Berger, G., Chen, E.Y., deHaan, L., Hickie, I., Lavoie, S., McHugh, M.J., Mossaheb, N., Nieman, D.H., Nordentoft, M., Riecher-Rossler, A., Schaefer, M., Schlogelhofer, M., Smesny, S., Thompson, A., Verma, S., Yung, A., Nelson, B., Opening the black box of cognitive-behavioural case management in ultra-high risk for psychosis clients. Psychother. Psychosom. 86:5 (2017), 292–299.
24. Hartmann, J.A., Nelson, B., Spooner, R., Amminger, G.P., Chanen, A.M., Davey, C., McHugh, M.J., Ratheesh, A., Treen, D., Yuen, H.P., McGorry, P., Broad clinical high-risk mental state (CHARMS): methodology of a cohort study validating criteria for pluripotent risk. Early Interv Psychiatry, 2017, 1–8 (Accepted for publication).
25. Kelleher, I., Lynch, F., Harley, M., Molloy, C., Roddy, S., Fitzpatrick, C., Cannon, M., Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies. Arch. Gen. Psychiatry 69:12 (2012), 1277–1283.
26. Koike, S., Takano, Y., Iwashiro, N., Satomura, Y., Suga, M., Nagai, T., Natsubori, T., Tada, M., Nishimura, Y., Yamasaki, S., Takizawa, R., Yahata, N., Araki, T., Yamasue, H., Kasai, K., A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project. Schizophr. Res. 143:1 (2013), 116–124.
27. Lee, T.Y., Kim, S.N., Correll, C.U., Byun, M.S., Kim, E., Jang, J.H., Kang, D.-H., Yun, J.-Y., Kwon, J.S., Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study. Schizophr. Res. 156:2–3 (2014), 266–271.
28. Lieberman, J.A., Drake, R.E., Sederer, L.I., Belger, A., Keefe, R., Perkins, D., Stroup, S., Science and recovery in schizophrenia. Psychiatr. Serv. 59:5 (2008), 487–496.
29. Lim, J., Rekhi, G., Rapisarda, A., Lam, M., Kraus, M., Keefe, R.S., Lee, J., Impact of psychiatric comorbidity in individuals at ultra high risk of psychosis - findings from the longitudinal youth at risk study (LYRIKS). Schizophr. Res. 164:1–3 (2015), 8–14.
30. Lin, A., Wood, S.J., Nelson, B., Beavan, A., McGorry, P., Yung, A.R., Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am. J. Psychiatry 172:3 (2015), 249–258.
31. Markulev, C., McGorry, P.D., Nelson, B., Yuen, H.P., Schaefer, M., Yung, A.R., Thompson, A., Berger, G., Mossaheb, N., Schlögelhofer, M., Smesny, S., de Haan, L., Riecher-Rössler, A., Nordentoft, M., Chen, E.Y.H., Verma, S., Hickie, I., Amminger, G.P., NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Intervention in Psychiatry 11 (2017), 418–428.
32. McGorry, P., Early intervention, youth mental health: the value of translational research for reform and investment in mental health. Australasian Psychiatry 22:3 (2014), 225–227.
33. McGorry, P., Nelson, B., Why we need a Transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry 73:3 (2016), 191–192.
34. McGorry, P.D., Hickie, I.B., Yung, A.R., Pantelis, C., Jackson, H.J., Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40:8 (2006), 616–622.
35. McGorry, P.D., Nelson, B., Goldstone, S., Yung, A.R., Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can. J. Psychiatr. 55:8 (2010), 486–497.
36. McGorry, P.D., Nelson, B., Markulev, C., Yuen, H.P., Schafer, M.R., Mossaheb, N., Schlogelhofer, M., Smesny, S., Hickie, I.B., Berger, G.E., Chen, E.Y., de Haan, L., Nieman, D.H., Nordentoft, M., Riecher-Rossler, A., Verma, S., Thompson, A., Yung, A.R., Amminger, G.P., Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial. JAMA Psychiatry 74:1 (2017), 19–27.
37. McHugh, M.J., McGorry, P., Hickie, I., Thompson, A., deHaan, L., Mossaheb, N., Smesny, S., Wood, S., Nieman, D.H., Nordentoft, M., Yung, A., Nelson, B., Defining trait and state risk for psychosis: evidence to maintain the status quo. Early Interv Psychiatry, 2016, 75 Milan, Italy.
38. Michel, C., Ruhrmann, S., Schimmelmann, B.G., Klosterkotter, J., Schultze-Lutter, F., Course of clinical high-risk states for psychosis beyond conversion. Eur. Arch. Psychiatry Clin. Neurosci. 268:1 (2018), 39–48.
39. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979), 382–389.
40. Nelson, B., Hughes, A., Leicester, S., Stratford, J., Polari, A., Hughes, F., Yung, A., Group, T.P.M.W, A Stich in Time: Intervention for Young Peopleat Ultra High Risk of Psychosis. 2014, Orygen Youth Health Research Centre, Melbourne, Australia.
41. Nelson, B., Yuen, H.P., Wood, S.J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D.L., Brewer, W.J., Francey, S.M., Amminger, G.P., Thompson, A., McGorry, P.D., Yung, A.R., Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70:8 (2013), 793–802.
42. Nelson, M.T., Seal, M.L., Pantelis, C., Phillips, L.J., Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci. Biobehav. Rev. 37:3 (2013), 317–327.
43. Nelson, B., Yuen, H.P., Lin, A., Wood, S.J., McGorry, P.D., Hartmann, J.A., Yung, A.R., Further examination of the reducing transition rate in ultra high risk for psychosis samples: the possible role of earlier intervention. Schizophr. Res. 174:1–3 (2016), 43–49.
44. Nelson, B., Amminger, G.P., Yuen, H.P., Wallis, N., M, J.K., Dixon, L., Carter, C., Loewy, R., Niendam, T.A., Shumway, M., Morris, S., Blasioli, J., McGorry, P.D., Staged treatment in early psychosis: a sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. Early Interv Psychiatry 0 (2017), 1–15.
45. van Os, J., Guloksuz, S., A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry 16:2 (2017), 200–206.
46. van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Bernardo, M., Arango, C., Fleischhacker, W., Lachaux, B., Kane, J.M., Standardized remission criteria in schizophrenia. Acta Psychiatr. Scand. 113:2 (2006), 91–95.
47. Polari, A., Nelson, B., Yung, A., Does reason for referral to UHR clinics predict transition to psychosis?. Early Interv Psychiatry, 2010, 108 Amsterdam, The Netherlands.
48. Rapado-Castro, M., McGorry, P.D., Yung, A., Calvo, A., Nelson, B., Sources of clinical distress in young people at ultra high risk of psychosis. Schizophr. Res. 165:1 (2015), 15–21.
49. Salokangas, R.K., Ruhrmann, S., von Reventlow, H.G., Heinimaa, M., Svirskis, T., From, T., Luutonen, S., Juckel, G., Linszen, D., Dingemans, P., Birchwood, M., Patterson, P., Schultze-Lutter, F., Klosterkotter, J., group, E, Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr. Res. 138:2–3 (2012), 192–197.
50. Schiffman, J., Carpenter, W.T., Attenuated psychosis syndrome: benefits of explicit recognition. Shanghai Arch Psychiatry 27:1 (2015), 48–51.
51. Schlosser, D.A., Jacobson, S., Chen, Q., Sugar, C.A., Niendam, T.A., Li, G., Bearden, C.E., Cannon, T.D., Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr. Bull. 38:6 (2012), 1225–1233.
52. Schultze-Lutter, F., Michel, C., Schmidt, S.J., Schimmelmann, B.G., Maric, N.P., Salokangas, R.K., Riecher-Rossler, A., van der Gaag, M., Nordentoft, M., Raballo, A., Meneghelli, A., Marshall, M., Morrison, A., Ruhrmann, S., Klosterkotter, J., EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 30:3 (2015), 405–416.
53. Simon, A.E., Borgwardt, S., Riecher-Rossler, A., Velthorst, E., de Haan, L., Fusar-Poli, P., Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis. Psychiatry Res. 209:3 (2013), 266–272.
54. The-PACE-Manual-Writing-Group, The PACE Manual: A Treatment Approach for Young People at Ultra High Risk of Psychosis. 2012, Orygen Youth Health, Melbourne, Australia.
55. Velthorst, E., Nieman, D.H., Becker, H.E., van de Fliert, R., Dingemans, P.M., Klaassen, R., de Haan, L., van Amelsvoort, T., Linszen, D.H., Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr. Res. 109:1–3 (2009), 60–65.
56. WHO, W.H.O., Global Report on Diabetes. 2016.
57. Winograd, G., Cohen, P., Chen, H., Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J. Child Psychol. Psychiatry 49:9 (2008), 933–941.
58. de Wit, S., Schothorst, P.F., Oranje, B., Ziermans, T.B., Durston, S., Kahn, R.S., Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. Eur. Neuropsychopharmacol. 24:6 (2014), 865–873.
59. Woods, S.W., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., McGlashan, T.H., Validity of the prodromal risk syndrome for first psychosis: findings from the north American Prodrome longitudinal study. Schizophr. Bull. 35:5 (2009), 894–908.
60. Woods, S.W., Walsh, B.C., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R., Perkins, D.O., Seidman, L.J., Tarbox, S.I., Tsuang, M.T., Walker, E.F., McGlashan, T.H., Current status specifiers for patients at clinical high risk for psychosis. Schizophr. Res. 158:1–3 (2014), 69–75.
61. Yung, A.R., McGorry, P.D., McFarlane, C.A., Jackson, H.J., Patton, G.C., Rakkar, A., Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22:2 (1996), 283–303.
62. Yung, A., Phillips, L., Yuen, H., McGorry, P., Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 67:2–3 (2004), 131–142.
63. Yung, A.R., Phillips, L.J., Yuen, H.P., McGorry, P.D., Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 67:2–3 (2004), 131–142.
64. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., Francey, S.M., Cosgrave, E.M., Killackey, E., Stanford, C., Godfrey, K., Buckby, J., Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:11−12 (2005), 964–971.
65. Yung, A.R., Yuen, H.P., Berger, G., Francey, S., Hung, T.C., Nelson, B., Phillips, L., McGorry, P., Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr. Bull. 33:3 (2007), 673–681.
66. Yung, A.R., Nelson, B., Thompson, A., Wood, S.J., The psychosis threshold in ultra high risk (prodromal) research: is it valid?. Schizophr. Res. 120:1–3 (2010), 1–6.
67. Zanarini, M.C., Frankenburg, F.R., Reich, D.B., Fitzmaurice, G., Time to attainment of recovery from borderline personality disorder and stability of recovery: a 10-year prospective follow-up study. Am. J. Psychiatry 167:6 (2010), 663–667.